Oppenheimer Holdings OPY Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $445.1M+21.0% | $472.63M+25.9% | $424.44M+13.7% | $373.18M+12.9% | $367.83M+4.2% | ||
| $472.1M+44.6% | $366.66M+2.3% | $392.8M+16.2% | $340.97M+8.3% | $326.45M+3.4% | ||
| -$27M-165% | $105.97M+521% | $31.64M-10.6% | $32.21M+103% | $41.38M+10.5% | ||
| -6.1%-17.3pp | 22.4%+17.9pp | 7.5%-2.0pp | 8.6%+3.8pp | 11.2%+0.6pp | ||
| $18.69M-12.7% | $20.14M-5.7% | $22.5M-6.7% | $22.53M+2.5% | $21.4M+4.1% | ||
| $211.1M+96.6% | -$185.5M-509% | —— | —— | $107.4M+13.8% | ||
| -$27M-165% | $105.97M+521% | $31.64M-10.6% | $32.21M+103% | $41.38M+10.5% | ||
| -$6.43M-160% | $32.05M+406% | $9.92M-8.6% | $10.54M+88.2% | $10.72M-8.5% | ||
| -$20.58M-167% | $74.36M+593% | $21.71M-11.4% | $21.67M+111% | $30.66M+17.7% | ||
| -4.6%-13.0pp | 15.7%+12.9pp | 5.1%-1.4pp | 5.8%+2.7pp | 8.3%+1.0pp | ||
| -$1.93-171% | $6.51+608% | $1.90-12.0% | $1.91+108% | $2.72+14.8% | ||
| -$24.35M-155% | $108.72M+450% | $34.39M-9.7% | $34.96M+88.3% | $44.13M+9.9% | ||
| -5.5%-17.5pp | 23%+17.7pp | 8.1%-2.1pp | 9.4%+3.8pp | 12%+0.6pp | ||
| -$27M-165% | $105.97M+521% | $31.64M-10.6% | $32.21M+103% | $41.38M+10.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Oppenheimer Holdings's revenue?
- Oppenheimer Holdings (OPY) generated $1.7B in revenue over the trailing twelve months, up 18.5% year over year.
- Is Oppenheimer Holdings profitable?
- Oppenheimer Holdings reported $97.2M in net income over the trailing twelve months, a 5.7% net margin.
- What is Oppenheimer Holdings's earnings per share?
- Oppenheimer Holdings's diluted EPS over the trailing twelve months is $8.39.
- Where does Oppenheimer Holdings's income statement data come from?
- Every line is extracted from Oppenheimer Holdings's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
